Fundamental dimension Equity attribute | ECLLeader $290.28▼-0.69% Cap $81.37BP/E 38.7x QuantScore53/100 | CECOPeer $57.49▲+1.36% Cap $3.37BP/E -98.8x QuantScore47/100 | CLHPeer $318.76▼-0.69% Cap $16.83BP/E 38.5x QuantScore53/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
96/100 |
23/100 |
95/100 |
Valuation Multiples, PEG & DCF upside | 34/100 | 31/100 | 29/100 |
Health Piotroski, Altman Z, leverage & liquidity | 52/100 | 29/100 | 55/100 |
Growth Revenue / earnings growth & margins | 26/100 | 79/100 | 18/100 |
Sentiment Analyst ratings, targets & revisions | 59/100 | 73/100 | 70/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 38.7x | -98.8x | 38.5x |
Forward P/E (next FY) | 35.6x | 25.0x | 31.6x |
EV / EBITDA (TTM) | 25.0x | 130.4x | 16.0x |
Price / Sales | 4.8x | 3.7x | 2.7x |
Price / Free Cash Flow | 43.4x | -295.6x | 86.5x |
PEG ratio | -72.96 | 0.71 | 2.49 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 3 / 9 | 7 / 9 |
Altman Z-Score | 4.15 (Safe) | 1.58 (Distress) | 3.92 (Safe) |
Total debt / equity | 1.37 | 0.37 | 1.04 |
Quick ratio | 1.6x | 1.2x | 1.8x |
Interest coverage | 9.7x | 0.4x | 4.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +2.2% | +38.8% | +2.4% |
Net income growth YoY | -1.7% | +286.3% | -2.8% |
Gross margin (TTM) | 44.1% | 32.7% | 26.6% |
Operating margin (FY) | 18.1% | 6.7% | 11.2% |
FCF margin (FY) | 11.8% | -0.7% | 7.3% |
5. Trailing price performancePrice change over period |
1M return | +4.8% | -21.1% | +0.9% |
3M return | +7.4% | -24.0% | +4.9% |
6M return | +7.1% | -11.4% | +3.2% |
Year to date | +9.9% | -3.9% | +35.9% |
1Y return | +4.1% | +10.2% | +29.9% |
3Y return | +80.0% | +270.2% | +105.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $194.64 -32.9% premium | $44.54 -22.5% premium | $121.81 -61.8% premium |
Wall Street consensus target | $326.38 +12.4% · range $275.00–$360.00 | $106.80 +85.8% · range $85.00–$125.00 | $363.70 +14.1% · range $335.00–$390.00 |
Consensus stance | 78% Buy19% Hold3% Sell | 71% Buy29% Hold-0% Sell | 68% Buy32% Hold-0% Sell |